CARL
Price
$18.60Alerts
Change
+$3.89 (+26.44%)
Updated
Nov 11 closing price
Capitalization
396.44M
Intraday BUY SELL Signals
HQY
Price
$103.03Alerts
Change
-$0.51 (-0.49%)
Updated
Nov 11 closing price
Capitalization
8.57B
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CARL vs HQY

CARL vs HQY Comparison Chart in %
View a ticker or compare two or three
VS
CARL vs. HQY commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARL is a Hold and HQY is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CARL with price predictions
Nov 10, 2026

CARL saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for CARL moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 17 similar instances where the indicator exited the overbought zone. In 16 of the 17 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CARL as a result. In 23 of 26 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

CARL moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CARL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

CARL broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CARL entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CARL just turned positive on October 22, 2026. Looking at past instances where CARL's MACD turned positive, the stock continued to rise in 9 of 11 cases over the following month. The odds of a continued upward trend are 82%.

The 10-day moving average for CARL crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.

Following a +6.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where CARL advanced for three days, in 59 of 72 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.706) is normal, around the industry mean (4.477). P/E Ratio (-6.214) is within average values for comparable stocks, (13.414). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (6.596) is also within normal values, averaging (6.065).

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. CARL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 79 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CARL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
a Summary for HQY with price predictions
Nov 10, 2026

HQY in upward trend: 10-day moving average broke above 50-day moving average on October 26, 2026

The 10-day moving average for HQY crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on November 10, 2026. You may want to consider a long position or call options on HQY as a result. In 63 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.

HQY moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where HQY advanced for three days, in 222 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

The Aroon Indicator entered an Uptrend today. In 195 of 299 cases where HQY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.

Bearish Trend Analysis

The 10-day RSI Indicator for HQY moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 similar instances where the indicator moved out of overbought territory. In 30 of the 46 cases, the stock moved lower in the following days. This puts the odds of a move lower at 65%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HQY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.

HQY broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. HQY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 45 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 66 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.307) is normal, around the industry mean (4.477). P/E Ratio (37.011) is within average values for comparable stocks, (13.414). Projected Growth (PEG Ratio) (1.287) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (6.035) is also within normal values, averaging (6.065).

The Tickeron PE Growth Rating for this company is 85 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

FUNDAMENTALS RATINGS
HQY: Fundamental Ratings
HQY
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
45
SMR RATING
1..100
66
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CARLHQY
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
65%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 16 days ago
82%
Bullish Trend 10 days ago
73%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 16 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
66%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
65%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (CARL: $14.71 vs. HQY: $103.54)
Brand notoriety: CARL and HQY are both not notable
Both companies represent the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: CARL: 118% vs. HQY: 74%
Market capitalization -- CARL: $396.44M vs. HQY: $8.57B
CARL [@Services to the Health Industry] is valued at $396.44M. HQY’s [@Services to the Health Industry] market capitalization is $8.57B. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $708 to $49.18B. The average market capitalization across the [@Services to the Health Industry] industry is $3.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CARL’s FA Score shows that 1 FA rating(s) are green while HQY’s FA Score has 0 green FA rating(s).

  • CARL’s FA Score: 1 green, 4 red.
  • HQY’s FA Score: 0 green, 5 red.
According to our system of comparison, HQY is a better buy in the long-term than CARL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CARL’s TA Score shows that 3 TA indicator(s) are bullish while HQY’s TA Score has 6 bullish TA indicator(s).

  • CARL’s TA Score: 3 bullish, 6 bearish.
  • HQY’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, HQY is a better buy in the short-term than CARL.

Price Growth

CARL (@Services to the Health Industry) experienced а +2.15% price change this week, while HQY (@Services to the Health Industry) price change was +1.48% for the same time period.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was +0.67%. For the same industry, the average monthly price growth was +2.59%, and the average quarterly price growth was +28.54%.

Reported Earning Dates

HQY is expected to report earnings on Dec 01, 2026.

Industries' Descriptions

@Services to the Health Industry (+0.67% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

View a ticker or compare two or three
Interact to see
Advertisement

CARL and

Correlation & Price change

A.I.dvisor tells us that CARL and TEM have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CARL and TEM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CARL
1D Price
Change %
CARL100%
-8.35%
TEM - CARL
31%
Poorly correlated
-4.62%
TDOC - CARL
29%
Poorly correlated
-0.45%
PRVA - CARL
27%
Poorly correlated
-0.69%
WEAV - CARL
26%
Poorly correlated
N/A
HQY - CARL
24%
Poorly correlated
+1.40%
More

HQY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HQY has been loosely correlated with EVCM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HQY jumps, then EVCM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HQY
1D Price
Change %
HQY100%
+1.40%
EVCM - HQY
47%
Loosely correlated
-13.30%
CPAY - HQY
46%
Loosely correlated
+0.36%
HUBS - HQY
46%
Loosely correlated
-4.34%
WAY - HQY
45%
Loosely correlated
+0.41%
ALKT - HQY
43%
Loosely correlated
-0.42%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CAOS91.450.15
+0.16%
Alpha Architect Tail Risk ETF (CAOS)
SNPG55.78N/A
N/A
Xtrackers S&P 500 Growth Scored & Screened ETF (SNPG)
IWP128.90-0.23
-0.18%
iShares Russell Mid-Cap Growth ETF (IWP)
IG19.82-0.03
-0.18%
Principal Investment Grade Corporate ETF (IG)
RTRE23.88-0.19
-0.79%
Rareview Total Return Bond ETF (RTRE)